REFERENCES
- Mahevas M, Lescure FX, Boffa JJ, . Renal sarcoidosis, clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine. 2009;88:98–106.
- Kettritz R. The protean face of sarcoidosis revisited. Nephrol Dial Transplant. 2006;21:2690–2694.
- Gobel U, Kettritz R, Schneider W, Luft FC. The protean face of sarcoidosis. J Am Soc Nephrol. 2001;12:616–623.
- Jose MD, McGregor DO, Lynn KL. Renal sarcoidosis in Christchurch, New Zealand 1970–1998. Aust NZ J Med. 1999;29:770–775.
- Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestation of sarcoidosis in various organs. Radiographics. 2004;24:87–104.
- Mizunoe S, Yamasaki T, Tokimatsu I, . Sarcoidosis associated with renal masses on computed tomography. Intern Med. 2006;45(5):279–282.
- Rajakariar R, Sharples EJ, Raftery MJ, Sheaff M, Yaqoob MM. Sarcoid tubulo-interstitial nephritis: Long-term outcome and response to corticosteroid therapy. Kidney Int. 2006;70:165–169.
- Miller BW, Miller SB, McKenzie CR, Davila RM. Granulomatous interstitial nephritis: Drug hypertensivity, infection, or sarcoidosis? Am J Kidney Dis. 1997;30:586–588.
- Beneteau-Burnat B, Baudin B. Angiotensin-converting enzyme: Clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci. 1991;28:337–356.
- Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–755.